Click for best price
Prostate Cancer Molecular Diagnostics Market Size, Share 2023
A molecular approach for diagnosing prostate cancer
This report aims to provide a comprehensive presentation of the global market for Prostate Cancer Molecular Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Prostate Cancer Molecular Diagnostics. This report contains market size and forecasts of Prostate Cancer Molecular Diagnostics in global, including the following market information:
Global Prostate Cancer Molecular Diagnostics Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global top five companies in 2022 (%)
The global Prostate Cancer Molecular Diagnostics market was valued at US$ million in 2022 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
PCR Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Prostate Cancer Molecular Diagnostics include Qiagen, Foundationmedicine, Genetech, Gpmedical, Premed, Berryoncology, Gene+, Annoroad and Topgen, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Prostate Cancer Molecular Diagnostics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Prostate Cancer Molecular Diagnostics Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Prostate Cancer Molecular Diagnostics Market Segment Percentages, by Type, 2022 (%)
PCR
FISH
DNA Sequencing
Gene Chip
Global Prostate Cancer Molecular Diagnostics Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Prostate Cancer Molecular Diagnostics Market Segment Percentages, by Application, 2022 (%)
Clinical Diagnosis
Drug Screening
Research
Global Prostate Cancer Molecular Diagnostics Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Prostate Cancer Molecular Diagnostics Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Prostate Cancer Molecular Diagnostics revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Prostate Cancer Molecular Diagnostics revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Qiagen
Foundationmedicine
Genetech
Gpmedical
Premed
Berryoncology
Gene+
Annoroad
Topgen
Geneis
Outline of Major Chapters:
Chapter 1: Introduces the definition of Prostate Cancer Molecular Diagnostics, market overview.
Chapter 2: Global Prostate Cancer Molecular Diagnostics market size in revenue.
Chapter 3: Detailed analysis of Prostate Cancer Molecular Diagnostics company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Prostate Cancer Molecular Diagnostics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Prostate Cancer Molecular Diagnostics Market, Global Outlook and Forecast 2023-2030 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
62 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Prostate Cancer Molecular Diagnostics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Prostate Cancer Molecular Diagnostics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Prostate Cancer Molecular Diagnostics Overall Market Size
2.1 Global Prostate Cancer Molecular Diagnostics Market Size: 2022 VS 2030
2.2 Global Prostate Cancer Molecular Diagnostics Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Prostate Cancer Molecular Diagnostics Players in Global Market
3.2 Top Global Prostate Cancer Molecular Diagnostics Companies Ranked by Revenue
3.3 Global Prostate Cancer Molecular Diagnostics Revenue by Companies
3.4 Top 3 and Top 5 Prostate Cancer Molecular Diagnostics Companies in Global Market, by Revenue in 2022
3.5 Global Companies Prostate Cancer Molecular Diagnostics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Prostate Cancer Molecular Diagnostics Players in Global Market
3.6.1 List of Global Tier 1 Prostate Cancer Molecular Diagnostics Companies
3.6.2 List of Global Tier 2 and Tier 3 Prostate Cancer Molecular Diagnostics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Prostate Cancer Molecular Diagnostics Market Size Markets, 2022 & 2030
4.1.2 PCR
4.1.3 FISH
4.1.4 DNA Sequencing
4.1.5 Gene Chip
4.2 By Type - Global Prostate Cancer Molecular Diagnostics Revenue & Forecasts
4.2.1 By Type - Global Prostate Cancer Molecular Diagnostics Revenue, 2018-2023
4.2.2 By Type - Global Prostate Cancer Molecular Diagnostics Revenue, 2024-2030
4.2.3 By Type - Global Prostate Cancer Molecular Diagnostics Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Prostate Cancer Molecular Diagnostics Market Size, 2022 & 2030
5.1.2 Clinical Diagnosis
5.1.3 Drug Screening
5.1.4 Research
5.2 By Application - Global Prostate Cancer Molecular Diagnostics Revenue & Forecasts
5.2.1 By Application - Global Prostate Cancer Molecular Diagnostics Revenue, 2018-2023
5.2.2 By Application - Global Prostate Cancer Molecular Diagnostics Revenue, 2024-2030
5.2.3 By Application - Global Prostate Cancer Molecular Diagnostics Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Prostate Cancer Molecular Diagnostics Market Size, 2022 & 2030
6.2 By Region - Global Prostate Cancer Molecular Diagnostics Revenue & Forecasts
6.2.1 By Region - Global Prostate Cancer Molecular Diagnostics Revenue, 2018-2023
6.2.2 By Region - Global Prostate Cancer Molecular Diagnostics Revenue, 2024-2030
6.2.3 By Region - Global Prostate Cancer Molecular Diagnostics Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Prostate Cancer Molecular Diagnostics Revenue, 2018-2030
6.3.2 US Prostate Cancer Molecular Diagnostics Market Size, 2018-2030
6.3.3 Canada Prostate Cancer Molecular Diagnostics Market Size, 2018-2030
6.3.4 Mexico Prostate Cancer Molecular Diagnostics Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Prostate Cancer Molecular Diagnostics Revenue, 2018-2030
6.4.2 Germany Prostate Cancer Molecular Diagnostics Market Size, 2018-2030
6.4.3 France Prostate Cancer Molecular Diagnostics Market Size, 2018-2030
6.4.4 U.K. Prostate Cancer Molecular Diagnostics Market Size, 2018-2030
6.4.5 Italy Prostate Cancer Molecular Diagnostics Market Size, 2018-2030
6.4.6 Russia Prostate Cancer Molecular Diagnostics Market Size, 2018-2030
6.4.7 Nordic Countries Prostate Cancer Molecular Diagnostics Market Size, 2018-2030
6.4.8 Benelux Prostate Cancer Molecular Diagnostics Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Prostate Cancer Molecular Diagnostics Revenue, 2018-2030
6.5.2 China Prostate Cancer Molecular Diagnostics Market Size, 2018-2030
6.5.3 Japan Prostate Cancer Molecular Diagnostics Market Size, 2018-2030
6.5.4 South Korea Prostate Cancer Molecular Diagnostics Market Size, 2018-2030
6.5.5 Southeast Asia Prostate Cancer Molecular Diagnostics Market Size, 2018-2030
6.5.6 India Prostate Cancer Molecular Diagnostics Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Prostate Cancer Molecular Diagnostics Revenue, 2018-2030
6.6.2 Brazil Prostate Cancer Molecular Diagnostics Market Size, 2018-2030
6.6.3 Argentina Prostate Cancer Molecular Diagnostics Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Prostate Cancer Molecular Diagnostics Revenue, 2018-2030
6.7.2 Turkey Prostate Cancer Molecular Diagnostics Market Size, 2018-2030
6.7.3 Israel Prostate Cancer Molecular Diagnostics Market Size, 2018-2030
6.7.4 Saudi Arabia Prostate Cancer Molecular Diagnostics Market Size, 2018-2030
6.7.5 UAE Prostate Cancer Molecular Diagnostics Market Size, 2018-2030
7 Prostate Cancer Molecular Diagnostics Companies Profiles
7.1 Qiagen
7.1.1 Qiagen Company Summary
7.1.2 Qiagen Business Overview
7.1.3 Qiagen Prostate Cancer Molecular Diagnostics Major Product Offerings
7.1.4 Qiagen Prostate Cancer Molecular Diagnostics Revenue in Global Market (2018-2023)
7.1.5 Qiagen Key News & Latest Developments
7.2 Foundationmedicine
7.2.1 Foundationmedicine Company Summary
7.2.2 Foundationmedicine Business Overview
7.2.3 Foundationmedicine Prostate Cancer Molecular Diagnostics Major Product Offerings
7.2.4 Foundationmedicine Prostate Cancer Molecular Diagnostics Revenue in Global Market (2018-2023)
7.2.5 Foundationmedicine Key News & Latest Developments
7.3 Genetech
7.3.1 Genetech Company Summary
7.3.2 Genetech Business Overview
7.3.3 Genetech Prostate Cancer Molecular Diagnostics Major Product Offerings
7.3.4 Genetech Prostate Cancer Molecular Diagnostics Revenue in Global Market (2018-2023)
7.3.5 Genetech Key News & Latest Developments
7.4 Gpmedical
7.4.1 Gpmedical Company Summary
7.4.2 Gpmedical Business Overview
7.4.3 Gpmedical Prostate Cancer Molecular Diagnostics Major Product Offerings
7.4.4 Gpmedical Prostate Cancer Molecular Diagnostics Revenue in Global Market (2018-2023)
7.4.5 Gpmedical Key News & Latest Developments
7.5 Premed
7.5.1 Premed Company Summary
7.5.2 Premed Business Overview
7.5.3 Premed Prostate Cancer Molecular Diagnostics Major Product Offerings
7.5.4 Premed Prostate Cancer Molecular Diagnostics Revenue in Global Market (2018-2023)
7.5.5 Premed Key News & Latest Developments
7.6 Berryoncology
7.6.1 Berryoncology Company Summary
7.6.2 Berryoncology Business Overview
7.6.3 Berryoncology Prostate Cancer Molecular Diagnostics Major Product Offerings
7.6.4 Berryoncology Prostate Cancer Molecular Diagnostics Revenue in Global Market (2018-2023)
7.6.5 Berryoncology Key News & Latest Developments
7.7 Gene+
7.7.1 Gene+ Company Summary
7.7.2 Gene+ Business Overview
7.7.3 Gene+ Prostate Cancer Molecular Diagnostics Major Product Offerings
7.7.4 Gene+ Prostate Cancer Molecular Diagnostics Revenue in Global Market (2018-2023)
7.7.5 Gene+ Key News & Latest Developments
7.8 Annoroad
7.8.1 Annoroad Company Summary
7.8.2 Annoroad Business Overview
7.8.3 Annoroad Prostate Cancer Molecular Diagnostics Major Product Offerings
7.8.4 Annoroad Prostate Cancer Molecular Diagnostics Revenue in Global Market (2018-2023)
7.8.5 Annoroad Key News & Latest Developments
7.9 Topgen
7.9.1 Topgen Company Summary
7.9.2 Topgen Business Overview
7.9.3 Topgen Prostate Cancer Molecular Diagnostics Major Product Offerings
7.9.4 Topgen Prostate Cancer Molecular Diagnostics Revenue in Global Market (2018-2023)
7.9.5 Topgen Key News & Latest Developments
7.10 Geneis
7.10.1 Geneis Company Summary
7.10.2 Geneis Business Overview
7.10.3 Geneis Prostate Cancer Molecular Diagnostics Major Product Offerings
7.10.4 Geneis Prostate Cancer Molecular Diagnostics Revenue in Global Market (2018-2023)
7.10.5 Geneis Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Prostate Cancer Molecular Diagnostics Market Opportunities & Trends in Global Market
Table 2. Prostate Cancer Molecular Diagnostics Market Drivers in Global Market
Table 3. Prostate Cancer Molecular Diagnostics Market Restraints in Global Market
Table 4. Key Players of Prostate Cancer Molecular Diagnostics in Global Market
Table 5. Top Prostate Cancer Molecular Diagnostics Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Prostate Cancer Molecular Diagnostics Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Prostate Cancer Molecular Diagnostics Revenue Share by Companies, 2018-2023
Table 8. Global Companies Prostate Cancer Molecular Diagnostics Product Type
Table 9. List of Global Tier 1 Prostate Cancer Molecular Diagnostics Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Prostate Cancer Molecular Diagnostics Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Prostate Cancer Molecular Diagnostics Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Prostate Cancer Molecular Diagnostics Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Prostate Cancer Molecular Diagnostics Revenue in Global (US$, Mn), 2024-2030
Table 14. By Application ? Global Prostate Cancer Molecular Diagnostics Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Prostate Cancer Molecular Diagnostics Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Prostate Cancer Molecular Diagnostics Revenue in Global (US$, Mn), 2024-2030
Table 17. By Region ? Global Prostate Cancer Molecular Diagnostics Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Prostate Cancer Molecular Diagnostics Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Prostate Cancer Molecular Diagnostics Revenue (US$, Mn), 2024-2030
Table 20. By Country - North America Prostate Cancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Prostate Cancer Molecular Diagnostics Revenue, (US$, Mn), 2024-2030
Table 22. By Country - Europe Prostate Cancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Prostate Cancer Molecular Diagnostics Revenue, (US$, Mn), 2024-2030
Table 24. By Region - Asia Prostate Cancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Prostate Cancer Molecular Diagnostics Revenue, (US$, Mn), 2024-2030
Table 26. By Country - South America Prostate Cancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Prostate Cancer Molecular Diagnostics Revenue, (US$, Mn), 2024-2030
Table 28. By Country - Middle East & Africa Prostate Cancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Prostate Cancer Molecular Diagnostics Revenue, (US$, Mn), 2024-2030
Table 30. Qiagen Company Summary
Table 31. Qiagen Prostate Cancer Molecular Diagnostics Product Offerings
Table 32. Qiagen Prostate Cancer Molecular Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 33. Qiagen Key News & Latest Developments
Table 34. Foundationmedicine Company Summary
Table 35. Foundationmedicine Prostate Cancer Molecular Diagnostics Product Offerings
Table 36. Foundationmedicine Prostate Cancer Molecular Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 37. Foundationmedicine Key News & Latest Developments
Table 38. Genetech Company Summary
Table 39. Genetech Prostate Cancer Molecular Diagnostics Product Offerings
Table 40. Genetech Prostate Cancer Molecular Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 41. Genetech Key News & Latest Developments
Table 42. Gpmedical Company Summary
Table 43. Gpmedical Prostate Cancer Molecular Diagnostics Product Offerings
Table 44. Gpmedical Prostate Cancer Molecular Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 45. Gpmedical Key News & Latest Developments
Table 46. Premed Company Summary
Table 47. Premed Prostate Cancer Molecular Diagnostics Product Offerings
Table 48. Premed Prostate Cancer Molecular Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 49. Premed Key News & Latest Developments
Table 50. Berryoncology Company Summary
Table 51. Berryoncology Prostate Cancer Molecular Diagnostics Product Offerings
Table 52. Berryoncology Prostate Cancer Molecular Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 53. Berryoncology Key News & Latest Developments
Table 54. Gene+ Company Summary
Table 55. Gene+ Prostate Cancer Molecular Diagnostics Product Offerings
Table 56. Gene+ Prostate Cancer Molecular Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 57. Gene+ Key News & Latest Developments
Table 58. Annoroad Company Summary
Table 59. Annoroad Prostate Cancer Molecular Diagnostics Product Offerings
Table 60. Annoroad Prostate Cancer Molecular Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 61. Annoroad Key News & Latest Developments
Table 62. Topgen Company Summary
Table 63. Topgen Prostate Cancer Molecular Diagnostics Product Offerings
Table 64. Topgen Prostate Cancer Molecular Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 65. Topgen Key News & Latest Developments
Table 66. Geneis Company Summary
Table 67. Geneis Prostate Cancer Molecular Diagnostics Product Offerings
Table 68. Geneis Prostate Cancer Molecular Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 69. Geneis Key News & Latest Developments
List of Figures
Figure 1. Prostate Cancer Molecular Diagnostics Segment by Type in 2022
Figure 2. Prostate Cancer Molecular Diagnostics Segment by Application in 2022
Figure 3. Global Prostate Cancer Molecular Diagnostics Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Prostate Cancer Molecular Diagnostics Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Prostate Cancer Molecular Diagnostics Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Prostate Cancer Molecular Diagnostics Revenue in 2022
Figure 8. By Type - Global Prostate Cancer Molecular Diagnostics Revenue Market Share, 2018-2030
Figure 9. By Application - Global Prostate Cancer Molecular Diagnostics Revenue Market Share, 2018-2030
Figure 10. By Type - Global Prostate Cancer Molecular Diagnostics Revenue, (US$, Mn), 2022 & 2030
Figure 11. By Type - Global Prostate Cancer Molecular Diagnostics Revenue Market Share, 2018-2030
Figure 12. By Application - Global Prostate Cancer Molecular Diagnostics Revenue, (US$, Mn), 2022 & 2030
Figure 13. By Application - Global Prostate Cancer Molecular Diagnostics Revenue Market Share, 2018-2030
Figure 14. By Region - Global Prostate Cancer Molecular Diagnostics Revenue Market Share, 2018-2030
Figure 15. By Country - North America Prostate Cancer Molecular Diagnostics Revenue Market Share, 2018-2030
Figure 16. US Prostate Cancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 17. Canada Prostate Cancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 18. Mexico Prostate Cancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 19. By Country - Europe Prostate Cancer Molecular Diagnostics Revenue Market Share, 2018-2030
Figure 20. Germany Prostate Cancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 21. France Prostate Cancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 22. U.K. Prostate Cancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 23. Italy Prostate Cancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 24. Russia Prostate Cancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 25. Nordic Countries Prostate Cancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 26. Benelux Prostate Cancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 27. By Region - Asia Prostate Cancer Molecular Diagnostics Revenue Market Share, 2018-2030
Figure 28. China Prostate Cancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 29. Japan Prostate Cancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 30. South Korea Prostate Cancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 31. Southeast Asia Prostate Cancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 32. India Prostate Cancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 33. By Country - South America Prostate Cancer Molecular Diagnostics Revenue Market Share, 2018-2030
Figure 34. Brazil Prostate Cancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 35. Argentina Prostate Cancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 36. By Country - Middle East & Africa Prostate Cancer Molecular Diagnostics Revenue Market Share, 2018-2030
Figure 37. Turkey Prostate Cancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 38. Israel Prostate Cancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 39. Saudi Arabia Prostate Cancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 40. UAE Prostate Cancer Molecular Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 41. Qiagen Prostate Cancer Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Foundationmedicine Prostate Cancer Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Genetech Prostate Cancer Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Gpmedical Prostate Cancer Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Premed Prostate Cancer Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Berryoncology Prostate Cancer Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Gene+ Prostate Cancer Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Annoroad Prostate Cancer Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Topgen Prostate Cancer Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Geneis Prostate Cancer Molecular Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
